All stock lists
Avalo Therapeutics, Inc. (NASDAQ:AVTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.80-0.13 (-1.88%)
Insider Score
––Not scored
AVTX Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AVTX Stock Insider Trading Activity
AVTX stock’s insider trading shows 12 sales on the open market for an estimated $2.07M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sullivan Christopher Ryan CFO | Sell | 12,394 | $16.33 | $202.44K | 23.7% | 39,900 | Sep 16, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Option exercise | 12,394 | $9.88 | $122.45K | 31.1% | 52,294 | Sep 16, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Sell | 10,185 | $17.62 | $179.46K | 20.3% | 39,900 | Sep 10, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Option exercise | 10,185 | $8.04 | $81.89K | 25.5% | 50,085 | Sep 10, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 679 | $8.04 | $5.46K | 1.3% | 52,455 | Aug 28, 2026 | — | Form 4 |
| Doyle Mittie Other | Sell | 679 | $20.00 | $13.58K | 1.3% | 51,776 | Aug 28, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Sell | 31,031 | $20.05 | $622.32K | 43.7% | 39,900 | Aug 18, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Option exercise | 31,031 | $9.88 | $306.59K | 77.8% | 70,931 | Aug 18, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Option exercise | 2,876 | $9.88 | $28.41K | 3.7% | 81,594 | Aug 17, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Option exercise | 37,945 | $9.88 | $374.90K | 93.1% | 78,718 | Aug 17, 2026 | — | Form 4 |
| Doyle Mittie Other | Sell | 1,000 | $20.00 | $20.00K | 1.9% | 51,776 | Aug 17, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Sell | 3,749 | $19.94 | $74.76K | 8.6% | 39,900 | Aug 17, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Sell | 37,945 | $19.85 | $753.33K | 46.5% | 43,649 | Aug 17, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 1,000 | $12.65 | $12.65K | 1.9% | 52,776 | Aug 17, 2026 | — | Form 4 |
| Riley Jennifer Other | Sell | 2,655 | $19.59 | $52.01K | 6.7% | 37,041 | Aug 11, 2026 | — | Form 4 |
| Doyle Mittie Other | Sell | 679 | $20.00 | $13.58K | 1.3% | 51,776 | Aug 10, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 679 | $8.04 | $5.46K | 1.3% | 52,455 | Aug 10, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 1,000 | $12.65 | $12.65K | 1.9% | 52,776 | Jul 27, 2026 | — | Form 4 |
| Doyle Mittie Other | Sell | 1,000 | $20.00 | $20.00K | 1.9% | 51,776 | Jul 27, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 2,875 | $12.65 | $36.37K | 5.6% | 54,651 | Jun 30, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 1,779 | $8.04 | $14.30K | 3.3% | 56,430 | Jun 30, 2026 | — | Form 4 |
| Doyle Mittie Other | Sell | 4,654 | $20.00 | $93.08K | 8.2% | 51,776 | Jun 30, 2026 | — | Form 4 |
| Doyle Mittie Other | Option exercise | 1,450 | $8.04 | $11.66K | 2.8% | 53,226 | Jun 23, 2026 | — | Form 4 |
| Doyle Mittie Other | Sell | 1,450 | $18.00 | $26.10K | 2.7% | 51,776 | Jun 23, 2026 | — | Form 4 |
| Riley Jennifer Other | Tax withheld | 588 | $13.10 | $7.70K | 1.5% | 39,696 | Jun 10, 2026 | — | Form 4 |
| VARKI PAUL Other | Tax withheld | 1,081 | $13.10 | $14.16K | 3.2% | 32,576 | Jun 10, 2026 | — | Form 4 |
| Sullivan Christopher Ryan CFO | Tax withheld | 138 | $13.10 | $1.81K | 0.3% | 40,773 | Jun 10, 2026 | — | Form 4 |
| Doyle Mittie Other | Tax withheld | 1,084 | $13.10 | $14.20K | 2.1% | 51,776 | Jun 10, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.